The FDA approves two new drugs for gonorrhoea treatment, with Dr. Reddy’s to market one in Thailand and South Africa.

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that ...

In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bimonthly injectable ...

An updated Canadian guideline on HIV prevention addresses the expanding range of medications available to reduce the risk of ...

Chemotherapy is often hindered by issues associated with deficient drug selectivity and ineluctable toxic effects.

A new study led by researchers at Emory University's Rollins School of Public Health, published Monday by JAMA Network Open, ...

The healthcare leader wants to make waves in a potentially highly lucrative market.

While the WHO is still assessing the scale of the impact of foreign aid cuts, access to PrEP medication is believed to have ...

Trump designated Venezuelan President Nicolás Maduro and his government allies as members of a foreign terrorist organization earlier this week.

It’s possible to produce a generic version of lenacapavir, a twice-yearly antiretroviral injection that both prevents and treats HIV, for as little as $25 per patient per year, according to a study ...

The Department is offering a series of HIV focused webinars. The first, led by Dr. Stephen Rawlings, covers the latest in HIV pre-exposure prophylaxis (PrEP) including a review of the twice-yearly ...